Christine Freeman

Christine Freeman is a Manager at Pfizer since September 2023, focusing on prostate cancer, global sickle cell, and hemophilia gene therapy. Additionally, Christine has served as the Director at the Sonia Nabeta Foundation since January 2019. An MBA graduate from Columbia Business School, Christine completed the degree in May 2023. Previous experience includes roles as an Analyst at Pura Vida Investments in late 2022, an MBA Summer Associate at Pfizer during summer 2022 specializing in mRNA commercial development, and a Senior Consultant and Tax Consultant at Deloitte from October 2014 to January 2019. Christine holds a Master of Accounting from the University of Miami Herbert Business School (2014) and a Bachelor of Business Administration in Accounting and Business Law from the same institution (2013).